Skip to main content

Table 3 Estimated lifetime economic benefits of reducing MeHg exposure in the 2008 children’s cohort according to the three study samples with the linear model

From: Economic evaluation of health consequences of prenatal methylmercury exposure in France

 

National sample

Brittany sample

Loire Atlantique sample

HHg concentrations ranges (μg/g)

[0.58;1.00]

[1.00;2.50]

[2.50;2.74]

[0.58;1.00]

[1.00;2.50]

[2.50;3.02]

[0.58;1.00]

[1.00;2.50]

[2.50;3.66]

B i

(€/individual)

From 0.58

[0.00;3,473]

[3,473;15,453]

[15,453;17,439]

[0.00;3,473]

[3,473;15,453]

[15,453;19,668]

[0.00;3,473]

[3,473;15,453]

[15,453;24,829]

From 1.00

 

[0.00;12,154]

[12,154;14,048]

 

[0.00;12,154]

[12,154;16,277]

 

[0.00;12,154]

[12,154;21,509]

From 2.50

  

[0.00;1,938]

  

[0.00;4.166]

  

[0.00;9,398]

B [range]

(€ billion)

(midpoint value)

From 0.58

 0.45

 1.09

 0.08

 0.33

 2.51

 0.18

 0.56

 1.63

 0.32

From 1.00

 

 0.70

 0.07

 

 1.61

 0.14

 

 1.04

 0.27

From 2.50

  

 0.005

  

 0.02

  

 0.07

TB

(€ billion)

(midpoint value)

From 0.58

From 1.00

From 2.50

From 0.58

From 1.00

From 2.50

From 0.58

From 1.00

From 2.50

1.62

[0.5;2.73]

0.77

[0.06;1.48]

0.005

[0.00;0.0098 ]

3.02

[1.08;4.93 ]

1.75

[0.12;3.39 ]

0.02

[0.00;0.042 ]

2.51

[0.84;4.13 ]

1.31

[0.19;2.43 ]

0.07

[0.00;0.15]

  1. Table3 presents the estimates of the economic impact for the linear model, expressed as individual benefits (Bi), benefits per range (B[range]) and the total benefits for one year (TB), associated with Hg exposures from the three cut-off points for the 2008 birth cohort assuming exposure distributions based on the three study samples.